ABSTRACT
Abstract Background A screening test for personality disorders was recently developed in Brazil, the Dimensional Clinical Personality Inventory – screening version (IDCP-SV). However, no relationship between this screening measure and other scales or external criteria was tested. Objective To seek for validity evidence based on related criteria (e.g., other psychological tests) and external criteria (e.g., sample demographics). Methods Sample comprised 804 participants from São Paulo (Brazil), most female and college students, with mean age equal to 29.65 (SD = 10.73). They answered the IDCP-SV and another screening for personality disorders (IPDS), a depression measure (EBADEP-screening), a scale assessing reasoning for living (EMVIVER), and a self-report for personality disorders categories assessment (SCID-II-PQ). Results IDCP-SV identified 46.4% of community sample as positive for personality disorders. The positive group showed the great mean for almost all comparisions, including psychological tests and the demographics characteristics, including large expressive effect sizes. Discussion Data suggest that the IDCP-SV discriminates a similar percentage of people from the community to what was reported previously using other screening measures; besides, the mean comparisons between groups showed good discriminative capacity by IDCP-SV items.
ABSTRACT
OBJECTIVES: The aims of this study were to evaluate acceptability and usefulness of the Korean version of Self-report Standardized Assessment of Personality-Abbreviated Scale (SAPAS-SR) as an instrument for screening patients with a personality disorder. METHODS: The Korean version of the SAPAS-SR was administered to a non-random sample of 186 psychiatric patients (155 patients with a personality disorder and 31 patients with no personality disorder). The International Classification of Diseases 10th version Personality Assessment Schedule was used as a gold standard in diagnosis of personality disorder. Receiver-operant-characteristics and validity indicators were determined. In addition, the SAPAS-SR was administered to 22 healthy men to examine the test-retest reliability. RESULTS: The area under the curve for the SAPAS-SR was 0.69 (95% confidence interval 0.59-0.79). The SAPAS-SR score of 4 or more correctly classified 67.2% of patients with a personality disorder. Sensitivity (0.67) and specificity (0.68) were slightly lower compared with the original English version. CONCLUSION: This study provides preliminary evidence of the usefulness of the Korean version of the SAPAS-SR as a self-administered instrument for screening personality disorders in the clinical population.